Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Apyx Medical Corp changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of APYX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders45245+2
Shares12.8M88.2K15.9M+3.21M (+25.3%)
Value$15.9M$109.3K$25.2M+$9.40M (+59.6%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Apyx Medical Corp at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to APYX in Q4 2024
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC3,169,800$5.01M0.35%
Perceptive Advisors LLC150,000$237.0K0.01%
Raymond James Financial Inc84,609$133.7K0.00%
Virtu Financial LLC10,421$16.0K0.00%
SBI Securities Co., Ltd.10$160.00%

Sold out (3)

Institutions that held Apyx Medical Corp at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of APYX in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Kestra Advisory Services, LLC124,189$154.0K
Envestnet Asset Management Inc10,726$13.3K
Northwestern Mutual Wealth Management Co103$128

Not filed for Q4 2024 yet (2)

Institutions that held Apyx Medical Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APYX in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James Financial Services Advisors, Inc.86,609$107.4K
Annapolis Financial Services, LLC1,568$1.95K